Cargando…

Improving Outcomes for Patients With Chronic Lymphocytic Leukemia

Mazyar Shadman, MD, MPH, and Amy Goodrich, CRNP, reviewed data regarding the mechanistic activity, efficacy, and safety of approved and emerging therapeutic options for chronic lymphocytic leukemia (CLL) and strategies for managing adverse events associated with approved therapies for CLL.

Detalles Bibliográficos
Autores principales: Shadman, Mazyar, Goodrich, Amy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857328/
https://www.ncbi.nlm.nih.gov/pubmed/33598332
http://dx.doi.org/10.6004/jadpro.2020.11.3.19
_version_ 1783646426662699008
author Shadman, Mazyar
Goodrich, Amy
author_facet Shadman, Mazyar
Goodrich, Amy
author_sort Shadman, Mazyar
collection PubMed
description Mazyar Shadman, MD, MPH, and Amy Goodrich, CRNP, reviewed data regarding the mechanistic activity, efficacy, and safety of approved and emerging therapeutic options for chronic lymphocytic leukemia (CLL) and strategies for managing adverse events associated with approved therapies for CLL.
format Online
Article
Text
id pubmed-7857328
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-78573282021-02-16 Improving Outcomes for Patients With Chronic Lymphocytic Leukemia Shadman, Mazyar Goodrich, Amy J Adv Pract Oncol Meeting Reports Mazyar Shadman, MD, MPH, and Amy Goodrich, CRNP, reviewed data regarding the mechanistic activity, efficacy, and safety of approved and emerging therapeutic options for chronic lymphocytic leukemia (CLL) and strategies for managing adverse events associated with approved therapies for CLL. Harborside Press LLC 2020-04 2020-04-01 /pmc/articles/PMC7857328/ /pubmed/33598332 http://dx.doi.org/10.6004/jadpro.2020.11.3.19 Text en © 2020 Harborside™ http://creativecommons.org/licenses/by-nc-nd/3.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Reports
Shadman, Mazyar
Goodrich, Amy
Improving Outcomes for Patients With Chronic Lymphocytic Leukemia
title Improving Outcomes for Patients With Chronic Lymphocytic Leukemia
title_full Improving Outcomes for Patients With Chronic Lymphocytic Leukemia
title_fullStr Improving Outcomes for Patients With Chronic Lymphocytic Leukemia
title_full_unstemmed Improving Outcomes for Patients With Chronic Lymphocytic Leukemia
title_short Improving Outcomes for Patients With Chronic Lymphocytic Leukemia
title_sort improving outcomes for patients with chronic lymphocytic leukemia
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857328/
https://www.ncbi.nlm.nih.gov/pubmed/33598332
http://dx.doi.org/10.6004/jadpro.2020.11.3.19
work_keys_str_mv AT shadmanmazyar improvingoutcomesforpatientswithchroniclymphocyticleukemia
AT goodrichamy improvingoutcomesforpatientswithchroniclymphocyticleukemia